These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 10334817)

  • 1. Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
    Campbell DJ; Kladis A; Briscoe TA; Zhuo J
    Hypertension; 1999 May; 33(5):1233-6. PubMed ID: 10334817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.
    Marceau F; Larrivée JF; Bouthillier J; Bachvarova M; Houle S; Bachvarov DR
    Am J Physiol; 1999 Dec; 277(6):R1568-78. PubMed ID: 10600901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
    Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
    Yekebas E; Treede H; Jochum M; Gippner-Steppert C; Bloechle C; Knoefel WT; Scholz J; Fink E; Izbicki JR
    Crit Care Med; 2000 Apr; 28(4):1119-27. PubMed ID: 10809293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
    Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renovascular hypertension in bradykinin B2-receptor knockout mice.
    Madeddu P; Milia AF; Salis MB; Gaspa L; Gross W; Lippoldt A; Emanueli C
    Hypertension; 1998 Sep; 32(3):503-9. PubMed ID: 9740617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
    Campbell DJ; Duncan AM; Kladis A
    Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bradykinin B2 receptors in the developmental changes of renal hemodynamics in the neonatal rat.
    el-Dahr SS; Yosipiv IV; Lewis L; Mitchell KD
    Am J Physiol; 1995 Dec; 269(6 Pt 2):F786-92. PubMed ID: 8594872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system.
    Yosipiv IV; Dipp S; El-Dahr SS
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F795-801. PubMed ID: 11592936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation.
    el-Dahr SS; Figueroa CD; Gonzalez CB; Müller-Esterl W
    Kidney Int; 1997 Mar; 51(3):739-49. PubMed ID: 9067906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of T-kinin on microvascular permeability and its modulation by peptidases in rat airways.
    Yamawaki I; Tamaoki J; Takeda Y; Chiyotani A; Sakai N; Kameyama S; Konno K
    J Appl Physiol (1985); 1995 Oct; 79(4):1129-33. PubMed ID: 8567553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inhibition of bradykinin receptors alters cardiovascular function in rats with an excess of circulating vasoconstrictors.
    Madeddu P; Pinna-Parpaglia P; Varoni MV; Demontis MP; Fattaccio MC; Anania V; Glorioso N
    Braz J Med Biol Res; 1994 Aug; 27(8):1985-93. PubMed ID: 7749390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
    Yosipiv IV; el-Dahr SS
    Am J Physiol; 1995 Aug; 269(2 Pt 2):F172-9. PubMed ID: 7544538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin increases catecholamine release via B2 receptors.
    Dendorfer A; Häuser W; Falias D; Dominiak P
    Pflugers Arch; 1996; 432(3 Suppl):R99-106. PubMed ID: 8994550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.